» Articles » PMID: 23036017

Pathogenesis of Abeta Oligomers in Synaptic Failure

Overview
Specialty Neurology
Date 2012 Oct 6
PMID 23036017
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

The soluble Abeta oligomers in brain are highly correlated with memory related synaptic dysfunctions in Alzheimer's disease (AD). However, more recent studies implicate the involvement of Abeta dimers and trimers in memory related AD pathology. Apparently, Abeta oligomers can bind with cellular prion protein at the membrane receptors, forming annular amyloid pores and membrane ion channels to induce aberrant spine cytoskeletal changes. Hence synapse targeting of Abeta oligomers involves activation of many receptors such as N-Methyl-D-aspartate (NMDA), alpha-amino-3- hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), nicotinic acetylcholine (nAChRs), p75 neurotrophin (p75NTR) following aberrant clustering of metabotropic glutamate receptors (mGluR5) leading to neuronal loss and LTP failure. In particular, NMDA and AMPA receptor activation by soluble amyloid oligomers involves calcium mediated mitochondrial dysfunction, decreased Ca((2+))/calmodulin-dependent protein kinase II (CaMKII) levels at the synapses accompanying dramatic loss of synaptic proteins such as postsynaptic density-95 (PSD-95), dynamin-1 and synaptophysin. This kind of receptor-Abeta oligomer interaction might eventually affect the neuronal membrane integrity by altering dielectric barrier, various synaptic proteins, spine morphology and density and P/Q calcium currents that might provoke a cascade of events leading to neuronal loss and memory failure. In this review, we try to explain in detail the various possible mechanisms that connect Abeta oligomers with synapse damage and memory failure.

Citing Articles

Xenografted human iPSC-derived neurons with the familial Alzheimer's disease APP mutation reveal dysregulated transcriptome signatures linked to synaptic function and implicate LINGO2 as a disease signaling mediator.

Qu W, Lam M, McInvale J, Mares J, Kwon S, Humala N Acta Neuropathol. 2024; 147(1):107.

PMID: 38918213 PMC: 11199265. DOI: 10.1007/s00401-024-02755-5.


Transmissible long-term neuroprotective and pro-cognitive effects of 1-42 beta-amyloid with A2T icelandic mutation in an Alzheimer's disease mouse model.

Celestine M, Jacquier-Sarlin M, Borel E, Petit F, Lante F, Bousset L Mol Psychiatry. 2024; 29(12):3707-3721.

PMID: 38871852 PMC: 11609088. DOI: 10.1038/s41380-024-02611-8.


Long term worsening of amyloid pathology, cerebral function, and cognition after a single inoculation of beta-amyloid seeds with Osaka mutation.

Celestine M, Jacquier-Sarlin M, Borel E, Petit F, Perot J, Herard A Acta Neuropathol Commun. 2023; 11(1):66.

PMID: 37087498 PMC: 10122826. DOI: 10.1186/s40478-023-01559-0.


New Insights into Microglial Mechanisms of Memory Impairment in Alzheimer's Disease.

Li N, Deng M, Hu G, Li N, Yuan H, Zhou Y Biomolecules. 2022; 12(11).

PMID: 36421736 PMC: 9687453. DOI: 10.3390/biom12111722.


Pathological changes induced by Alzheimer's brain inoculation in amyloid-beta plaque-bearing mice.

Lam S, Herard A, Boluda S, Petit F, Eddarkaoui S, Cambon K Acta Neuropathol Commun. 2022; 10(1):112.

PMID: 35974399 PMC: 9380345. DOI: 10.1186/s40478-022-01410-y.